45% of dementias can be prevented with some easily implemented strategies
A study showed that about 45% of dementias are preventable through lifestyle modifications. The societal impacts of this research include reducing financial burdens on the health care system, improving social participation and population health, and […]
View moreNew Alzheimer’s drugs showing success slowing disease progression, especially when treated early
New monoclonal antibody therapies targeting beta-amyloid deposition in the brain have shown success in slowing the progression of Alzheimer’s disease, though the risk of serious side effects necessitates careful evaluation and discussion before initiating treatment.. [...]
View moreAdvanced treatments for neuromuscular disorders
Neuromuscular disorders are conditions that affect the structure and function of the peripheral nervous system, as well as all motor and sensory nerves. The predominant symptom of this group of disorders is progressive muscle weakness. […]
View moreNew provider joins Norton Neuroscience Institute Memory Center team
Physician assistant Kendall M. Wasz, PA-C, has joined the memory care team at Norton Neuroscience Institute. Kendall holds Master of Science degree in physician assistant studies from the University of Kentucky, Lexington, and earned her […]
View moreNorton Research Institute unveils state-of-the-art research laboratory
Norton Research Institute will expand research efforts with the unveiling of the new Norton Research Institute Clinical & Translational Research Laboratory. The 7,200-square-foot facility, located inside Norton Healthcare Pavilion in downtown Louisville, will afford ample space […]
View moreWays to make prescribing controlled substances safer
Safer controlled substance prescribing begins with a thorough patient workup, an appropriate diagnosis and a comprehensive treatment plan, according to Kelly C. Cooper, M.D., an addiction medicine specialist with Norton Behavioral Medicine. “We just tend [...]
View moreSciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve
The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]
View moreUpdated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s
In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]
View moreChristopher P. Rhyne, M.D., headache medicine specialist, has joined Norton Neuroscience Institute
Christopher P. Rhyne, M.D., is a headache medicine specialist at Norton Neuroscience Institute. He earned his medical degree from Windsor University School of Medicine, St. Kitts, West Indies. He completed his residency in family medicine […]
View moreDiagnosis and treatment for trigeminal neuralgia
The initial evaluation for trigeminal neuralgia is typically in primary care, but patients frequently also present to dental and ear, nose and throat settings, according to Brian M. Plato, D.O., a neurologist and headache specialist [...]
View moreShawn W. Adams, M.D., joins Norton Leatherman Spine
After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]
View moreButyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment
Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]
View more